The standard injection dosage of 1 to 2 mg per day, subcutaneously, five days per week, covers most therapeutic goals
Nationwide Reach, Local Care We represent clients across the country, giving each case the individual attention it deserves
BPC157 has demonstrated an exceptional safety profile across multiple studies with no evidence of organ toxicity, mutagenicity, or carcinogenicity. Sikiric et al., Journal of Physiology and Pharmacology Long-Term Safety and Human Use Although human clinical trials are limited, the peptide has been used extensively in animal models and self-experimentation circles with no long-term complications reported
These findings are subject to important limitations including confounding by indication, concurrent medication use, and selection bias
That is four full years of shelf life
What is GLP 1 for Weight Loss